BASIC GUIDE TO TEG INTERPRETATION

Similar documents
Dr. Susan Louw Haematopathologist NHLS / WITS / SASTH

Thromboelastograph : An Introduction. Andy N.D. Nguyen, M.D.

Using TEG in the ED, OR, and ICU. Don H. Van Boerum, MD, FACS

Dr Kate Talks, Consultant Haematologist, Newcastle upon Tyne Hospitals NHS Trust Nov 2012

Medical Staff, House Staff, Patient Care Centers, Outpatient Clinics and UC Med Labs Clients

ROTEM Basic Interpretation Guide

Disclosures. Thromboelastography. TEG Methodology. TEG Output. Thromboelastography (TEG): Basics & Clinical Applications

Primary hemostasis. Vascular endothelium Vasoconstriction : local tissue factor, nervous system

ROTEM delta. Targeted therapy stops the bleeding. Easy and safe handling Fast therapeutic decisions Advanced diagnostic safety

Princess Alexandra Hospital Emergency Department. Clinical Procedure. 1 Introduction

Clinical Procedure. ROTEM Trauma, Resuscitation. Princess Alexandra Hospital Emergency Department. 1 Introduction

Coagulation in perspective: Blood management. Objectives

Use of ROTEM from the Laboratory Perspective. A/Prof David Roxby SA Pathology

Emergency and Perioperative Hemostasis Testing: Which Assays Provide Helpful Information. Wayne Chandler, MD Laboratory Medicine Seattle Children s

TEG: The ABCs of Implementing Thromboelastography in a Trauma Center

Quality Assurance and Quality Control of Thromboelastography and Rotational Thromboelastometry: The UK NEQAS for Blood Coagulation Experience

Strategies for transfusion therapy and monitoring

Introducing WHITE PAPER

Antithrombosis Management for Pediatric VAD and Beyond

Optimising bleeding management: One hospital s experience DR DANIEL FAULKE

DEPARTMENT OF CLINICAL LABORATORY SCIENCES SCHOOL OF HEALTH TECHNOLOGY AND MANAGEMENT THE UNIVERSITY AT STONY BROOK STONY BROOK, NEW YORK

The Role Of Point of Care Coagulation Testing (POCCT) in Patient Blood Management. Elham Khalaf Adeli

Use of Thromboelastography in the Management of the Trauma Patient Rio Grande Trauma Conference

ROTEM/TEG. Circulation in trauma: From roadside to bedside. A/Prof David Roxby SA Pathology Transfusion Service South Australia

Factor Concentrates. More is better? Alexander Duncan MD Emory Medical Labs

Local vasoconstriction. is due to local spasm of the smooth muscle (symp. reflex) can be maintained by platelet vasoconstrictors

Pharmacology Lecture 5. Anticoagulants

Principles of Coagulation Testing. Andy Nguyen, MD 8/4/2010

Postpartum Haemorrhage make sure you give enough fibrinogen!

2 Thomas G. DeLoughery

ROTEM delta when every second counts

Sonoclot Analyzer User Guide

Thrombelastograph Analysis After Heparin Neutralization with Protamine and Heparinase During Cardiopulmonary Bypass

Time impact on non-activated and kaolin-activated blood samples in thromboelastography

ROTEM and Human Fibrinogen Concentrate Use in Pediatric Cardiac Surgery

Major Burns Debridement Case

iccnet CHSA Clinical Protocol - HEPARIN

Adv Pathophysiology Unit 4 Page 1 of 10. Learning Objectives for this file:

Applying ROTEM to the Management of Bleeding in Trauma

Lina Al-Lawama. Rama Al-Ashqar. Malik Al-Zohlof

Marcia L. Zucker, Ph.D. ZIVD LLC

ROTEM and Human Fibrinogen Concentrate Use in Pediatric Cardiac Surgery

Blood transfusion in special situations and poly-trauma. Dr Marina Karakantza Consultant Haematologist in Transfusion Medicine, LTHT

Update on the Direct Oral Anticoagulants (DOACs)

LABORATORY APPROACH TO BLEEDING DISORDERS DR NISHANTH PG 1 ST YEAR DEPARTMENT OF PATHOLOGY

Marcia L. Zucker, Ph.D. ZIVD LLC

New-Generation Thromboelastography. Comprehensive Evaluation of Citrated and Heparinized Blood Sample Storage Effect on Clot-Forming Variables

Amrita Banerjee, Shauna L. Blois, 1 R. Darren Wood. Introduction

Manejo de la transfusión de plaquetas. Ileana López-Plaza, MD

CONTRACTING ORGANIZATION: University of Texas Southwestern Medical Center Dallas, TX

Platelet Function Testing Kits (catalogue numbers PSK-001, PSK-002, PSK-003)

Coagulopathy Case-2. Andy Nguyen, M.D. 2009

Hemostasis/Thrombosis IV

Role of fibrinogen concentrate in coagulation management in complex cardio-vascular surgery

Transfusion & Non-transfusion Approaches to Bleeding

General News. Product Notes

Bivalirudin (Angiomax ) vs. Heparin during Peripheral Vascular Interventions: Which is Better and How to Decide?

Hemostasis. by Mohie-Aldien Elsayed

Pharmacotherapy Management in Patients with Extracorporeal Membrane Oxygenation

Marcia L. Zucker, Ph.D. ZIVD LLC

Proceeding of the ACVP/ASVCP Concurrent Annual Meetings

SEED Coagulation. Sysmex Educational Enhancement and Development April 2014

Acute Traumatic Coagulopathy

Differential effects of the direct thrombin inhibitor dabigatran etexilate vs warfarin on platelet function

Evaluation of Complex Coagulation Cases: Case-Based Illustrations of Important Issues

Pharmacotherapy Resuscitation in Acute Traumatic Coagulopathy: Ready for Prime Time? September 29, 2017

Index. Autoimmune thrombocytopenic purpura (AITP), 100, 102, 105, 108, 187 Automated platelet counters, , 108

Session 1 Topics. Vascular Phase of Hemostasis. Coagulation Pathway. Action of Unfractionated Heparin. Laboratory Monitoring of Anticoagulant Therapy

THE EFFECT OF THAWING FRESH FROZEN PLASMA AT VARIOUS TEMPERATURES ON IN VITRO COAGULATION FACTOR ACTIVITY

General News. Product Notes. Instrument Notice HELENA SALES FORCE TO: FROM: SUBJECT: HELENA POINT OF CARE ROUND-UP/US DOMESTIC DATE: 9/1/2009

Plasma Testing in the Clinical Coagulation Laboratory: New drugs, new problems.

Sysmex Educational Enhancement and Development No

3/17/2016. Antithrombin and heparin dose effects on measures of anticoagulation in first five days of infant-pediatric ECLS.

Note: The taller 100 x 13 mm tube is not designed to run on the ACL TOP. Plasma after centrifugation of these tubes must be placed in sample cups.

Alternative Haemostatic Agents in the Management of Obstetric Haemorrhage

DOACs: When and how to measure their anticoagulant effect

Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Temporal Aspects.

Factors That Promote Increase In POC Testing

Improving Outcomes of Cardiac Surgery with a Point-of-Care Based Transfusion Algorithm

SSAR-SGAR Jahreskongress SAOA Meeting November 7, 2013

Research Article Evaluation of the Utility of Thromboelastography in atertiarytraumacarecentre

Ch 13: Blood. What does blood do? Transport: Regulation: Protection:

Cryoprecipitate audit within six centres in New Zealand.

OERMATAN SULFATE: A NEW CONCEPT IN ANTITHROMBOTIC THERAPY

These handouts are only meant as a guide while you follow the presentation on the screen. Sometimes the speaker will change some of the slides.

UMass Memorial Medical Center Worcester, MA

Managing Massive Transfusions in diverse Patient Populations in a Non-Metropolitan Area

If not heparin for bypass then what? Dr Tony Moriarty Consultant Cardiac Anaesthetist Birmingham United Kingdom

Disseminated Intravascular Coagulopathy

Managing the Risks Associated with Anticoagulant Therapy. Steve McGlynn Specialist Principal Pharmacist (Cardiology) NHS Greater Glasgow and Clyde

Guideline for Theraputic Plasma Exchange

BLOOD TRANSFUSION PETER HUDSON CLINICAL SPECIALIST

BLOOD TRANSFUSION PETER HUDSON CLINICAL SPECIALIST

Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase

Each year, 5.8 million people die because of trauma. Uncontrolled bleeds

Sysmex Educational Enhancement & Development

Hemostasis and Thrombosis

UPDATE ON SPECIFIC ANTIDOTES FOR TARGET-SPECIFIC ORAL ANTICOAGULANTS

Hematotoxin producing snakes in Thailand พญ.ม ชฌ มา รอดเช อ พญ.อ สร ย หาญอ ท ยร ศม

REVIEW OF TRANEXAMIC ACID IN TRAUMA

Transcription:

BASIC GUIDE TO TEG INTERPRETATION

Cardiac Protocol All samples are kaolin activated Sample No. When Cup Type Why Do It? 1 On induction Plain (clear) cup and pin If heparin suspected use Gives baseline haemostatic profile heparinase bonded (blue) cup and pin as part of a split sample 2 Re-Warmed Heparinase bonded cup and Early identification of any (approx pin (blue) coagulopathy that starts to 36 O C) (2) develop during bypass 3 10 mins post Split sample: 1. Checks heparin reversal protamine Plain (clear) cup and pin Heparinase bonded cup and pin (blue) 2. Gives post bypass haemostatic profile identifies cause of coagulopathy in bleeding patient (see suggested treatment protocol) 4 Post op ITU Split sample: 1. If it is indicated by a if indicated Plain (clear) cup and pin Heparinase bonded cup and pin (blue) developing coagulopahy profile seen in samples 1-3 2. If patient is bleeding or going off clinically NB 1. When using two cups ensure Plain cup is on the left of the heparinase cup 2. This is the point the patient comes off the pump/ end of last anastomosis in off pump case.

Suggested Treatment Protocol For kaolin activated samples TEG Values Clinical Cause Suggested Treatment R between 11 14 min clotting factors X2 FFP or 8ml/kg (2) R greater than 14 min clotting factors X4 FFP or 16 ml/kg (2) MA between 42 47mm platelet function X 1 Platelet Pool G between 3.6 4.4 K (3) MA < 42 mm platelet function X 2 Platelet Pools G less than 3.6K (3) LY30 at 7.5% or greater, Primary fibrinolysis Antifibrinolytic of choice with CI less than 1.0 LY30 at 7.5% or greater, Secondary fibrinolysis Anticoagulant of choice with CI greater than 3.0 R less than 3 min Prothrombotic state Anticoagulant of choice MA greater than 75mm G greater than 15K NB 1. Blood product and antifibrinolytic treatment is only suggested if your patient is bleeding at a level you wish to treat 2. These guidelines apply after you have ruled out heparin as a cause for the long R time 3. A normal kaolin activated MA does not rule out platelet inhibitor effects. If the patient is/was on antiplatelet agents PlateletMapping results should be used to assess platelet function and hence need for treatment with platelets

What Does TEG Report? Clot strength (Platelet function) Clotting time (clotting factors) Clot kinetics Clot stability/ Clot breakdown

TEG Parameter Definitions R = Reaction time The reaction time is the time from when the blood was placed in the TEG analyser until the initial fibrin formation ie how long it takes for the blood to start to clot, and is therefore a measure of clotting factors K = Kinetic time The K time is a measure of the speed taken to reach a specific level of clot strength. Together with the alpha angle it is a measure of clot kinetics Alpha Angle Measures the speed of fibrin build-up and cross-linking (clot strengthening) MA = Maximum Amplitude The maximum amplitude represents the ultimate strength of the clot and is a measure of platelet function. It is a direct function of the maximum dynamic properties of fibrin and platelet bonding via GPIIb/IIIa. LY30 = Lysis 30 minutes after MA It shows any breakdown of the clot and therefore gives an idea of clot stability

TEG Directed Therapy For Bleeding Patient Low MA Platelets indicated Prolonged R (not heparin) FFP indicated Clot kinetics High LY30 antifibrinolytics indicated

Qualitative Analysis Normal Coagulopathy/anticoagulants Long R time Reduced platelet function Low MA Primary fibrinolysis High LY30 Hypercoagulable Short R time, High MA DIC Stage 1 hypercoagulable state with secondary fibrinolysis DIC Stage 2 hypocoagulable state

PlateletMapping There is a kit for monitoring the effect of platelet inhibiting drugs such as aspirin and clopidogrel. AA (if looking at aspirin) or ADP (if looking at clopidogrel) Represents fibrin & platelets unaffected by platelet inhibiting drugs ie platelets that are still functioning A (activated) represents fibrin only clot ie no platelet aggregation K or KH represents fibrin & thrombinactivated platelets ie maximum platelet aggregation The traces run for a maximum of 20 minutes. Overlaying the traces causes the software to calculate and display % inhibition and % function.

What To Look For In An Etest Numbers in min/max are changing Final value 1800 2300 Message etest ok If message is not at equilibrium retry If message is etest is off centre/out of range can be tweaked with trimmer tool report to Site Administrator

MEDICELL LTD 70-72 Ballards Lane (Rear) The Mews, Off Princes Avenue, London N3 2BU T: +44 (0)20 8371 9908 F: +44 (0)20 8371 9906 E: enquiries@medi-cell.co.uk www.medi-cell.co.uk ME59011.REV04 Medicell Basic Guide to TEG Interpretation